A Phase I Study of SB1518 for the Treatment of Advanced Lymphoid Malignancies.

Trial Profile

A Phase I Study of SB1518 for the Treatment of Advanced Lymphoid Malignancies.

Completed
Phase of Trial: Phase I

Latest Information Update: 28 Jun 2013

At a glance

  • Drugs Pacritinib (Primary)
  • Indications Diffuse large B cell lymphoma; Hodgkin's disease; Lymphoma; Lymphoproliferative disorders
  • Focus Adverse reactions
  • Most Recent Events

    • 28 Jun 2013 Pooled safety results of this trial and 3 other phase I and II trials will be presented at the 18th Congress of the European Hematology Association in June 2013. Results also published in a Cell Therapeutics media release.
    • 24 Sep 2012 Results were published online in the Journal of Oncology in September 2012.
    • 19 Apr 2012 Actual patient number 35 added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top